AquaBounty Technologies, Inc. (AQB)
0.90
+0.05
(+5.70%)
USD |
NASDAQ |
Nov 13, 16:00
0.8999
0.00 (0.00%)
After-Hours: 19:59
AquaBounty Technologies Enterprise Value : 4.575M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 4.575M |
| November 12, 2026 | 4.322M |
| November 11, 2026 | 4.696M |
| November 10, 2026 | 4.746M |
| November 09, 2026 | 4.888M |
| November 06, 2026 | 4.982M |
| November 05, 2026 | 4.836M |
| November 04, 2026 | 5.618M |
| November 03, 2026 | 6.609M |
| November 02, 2026 | 6.139M |
| October 30, 2026 | 6.087M |
| October 29, 2026 | 6.40M |
| October 28, 2026 | 6.139M |
| October 27, 2026 | 5.514M |
| October 26, 2026 | 5.878M |
| October 23, 2026 | 5.670M |
| October 22, 2026 | 5.201M |
| October 21, 2026 | 5.514M |
| October 20, 2026 | 5.878M |
| October 19, 2026 | 5.305M |
| October 16, 2026 | 5.670M |
| October 15, 2026 | 5.618M |
| October 14, 2026 | 5.305M |
| October 13, 2026 | 5.279M |
| October 12, 2026 | 5.148M |
| Date | Value |
|---|---|
| October 09, 2026 | 5.357M |
| October 08, 2026 | 4.962M |
| October 07, 2026 | 4.697M |
| October 06, 2026 | 4.442M |
| October 05, 2026 | 4.503M |
| October 02, 2026 | 4.706M |
| October 01, 2026 | 4.628M |
| September 30, 2026 | 4.711M |
| September 29, 2026 | 2.991M |
| September 28, 2026 | 2.996M |
| September 25, 2026 | 3.004M |
| September 24, 2026 | 2.651M |
| September 23, 2026 | 3.468M |
| September 22, 2026 | 3.725M |
| September 21, 2026 | 3.828M |
| September 18, 2026 | 3.982M |
| September 17, 2026 | 3.931M |
| September 16, 2026 | 3.828M |
| September 15, 2026 | 3.776M |
| September 14, 2026 | 4.034M |
| September 11, 2026 | 4.394M |
| September 10, 2026 | 3.570M |
| September 09, 2026 | 3.570M |
| September 08, 2026 | 3.931M |
| September 04, 2026 | 4.034M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.335B |
| Agenus, Inc. | 487.93M |
| Alnylam Pharmaceuticals, Inc. | 21.50B |
| Amgen, Inc. | 292.70B |
| Anika Therapeutics, Inc. | 160.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.175M |
| Total Expenses (Quarterly) | 1.175M |
| EPS Diluted (Quarterly) | -0.2882 |
| Earnings Yield | -501.5% |
| Normalized Earnings Yield | -527.37 |